XML 69 R58.htm IDEA: XBRL DOCUMENT
v3.23.2

Investments in and Advances to Unconsolidated Joint Ventures (Details) $ in Thousands | 1 Months Ended |  |  |
--- | --- | --- | --- | ---
Apr. 30, 2023 USD ($) property | Apr. 28, 2023 USD ($) property | Dec. 31, 2021 USD ($) | Jun. 30, 2023 USD ($) property joint_venture | Dec. 31, 2022 USD ($) property | Aug. 31, 2022 joint_venture property
Schedule of Equity Method Investments [Line Items] |  |  |  |  |  |
Investments in and advances to unconsolidated joint ventures | $ |  |  |  | $ 731,956 | $ 706,677 |
Medical Office JVs |  |  |  |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |  |  |  |
Property count | 2 |  |  |  |  |
Number of unconsolidated joint ventures (in joint ventures) | joint_venture |  |  |  | 2 |  |
HCP Ventures IV, LLC |  |  |  |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |  |  |  |
Property count | 1 | 1 |  |  |  |
Investment ownership percentage | 80.00% | 80.00% |  | 20.00% |  |
Cash paid | $ | $ 4,000 | $ 4,000 |  |  |  |
Suburban Properties, LLC |  |  |  |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |  |  |  |
Investment ownership percentage |  |  |  | 67.00% |  |
Other Non-Reporting Segment | SWF SH JV |  |  |  |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |  |  |  |
Property count |  |  |  | 19 |  |
Investment ownership percentage |  |  |  | 54.00% |  |
Equity method investments | $ |  |  |  | $ 341,894 | 345,978 |
Lab | South San Francisco JVs |  |  |  |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |  |  |  |
Property count |  |  |  | 7 |  |
Investment ownership percentage |  |  |  | 70.00% |  | 70.00%
Equity method investments | $ |  |  |  | $ 337,450 | 309,969 |
Number of unconsolidated joint ventures (in joint ventures) | joint_venture |  |  |  |  |  | 7
Lab | Lab JV |  |  |  |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |  |  |  |
Property count |  |  |  | 1 |  |
Investment ownership percentage |  |  |  | 49.00% |  |
Equity method investments | $ |  |  |  | $ 28,863 | 26,601 |
Lab | Needham Land Parcel JV |  |  |  |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |  |  |  |
Property count |  |  |  | 0 |  |
Investment ownership percentage |  |  | 38.00% | 38.00% |  |
Equity method investments | $ |  |  |  | $ 15,697 | $ 15,391 |
Cash paid | $ |  |  | $ 13,000 |  |  |
Lab | Life Science JV in San Francisco, California |  |  |  |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |  |  |  |
Property count |  |  |  |  |  | 7
Lab | Life Science JV in San Francisco, California | Life Science JV in San Francisco, California |  |  |  |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |  |  |  |
Investment ownership percentage |  |  |  |  |  | 30.00%
Outpatient Medical |  |  |  |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |  |  |  |
Property count |  |  |  |  | 3 |
Outpatient Medical | Medical Office JVs |  |  |  |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |  |  |  |
Property count |  |  |  | 2 |  |
Equity method investments | $ |  |  |  | $ 8,052 | $ 8,738 |
Outpatient Medical | Medical Office JVs | Minimum |  |  |  |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |  |  |  |
Investment ownership percentage |  |  |  | 20.00% |  |
Outpatient Medical | Medical Office JVs | Maximum |  |  |  |  |  |
Schedule of Equity Method Investments [Line Items] |  |  |  |  |  |
Investment ownership percentage |  |  |  | 67.00% |  |

X
- Definition Represents number of unconsolidated joint ventures between entity and an institutional capital partner. + References No definition available. + Details
Name: | peak_NumberOfUnconsolidatedJointVenture
Namespace Prefix: | peak_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 + Details
Name: | us-gaap_EquityMethodInvestmentOwnershipPercentage
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481664/323-10-45-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(10)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 25 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482810/280-10-50-25 + Details
Name: | us-gaap_EquityMethodInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of investment in equity method investee and investment in and advance to affiliate. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(18)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition The number of real estate properties owned as of the balance sheet date. + References No definition available. + Details
Name: | us-gaap_NumberOfRealEstateProperties
Namespace Prefix: | us-gaap_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition The cash outflow associated with the purchase of or advances to an equity method investments, which are investments in joint ventures and entities in which the entity has an equity ownership interest normally of 20 to 50 percent and exercises significant influence. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13 + Details
Name: | us-gaap_PaymentsToAcquireEquityMethodInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 + Details
Name: | us-gaap_ScheduleOfEquityMethodInvestmentsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_MedicalOfficeJVsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_HCPVenturesIVLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_SuburbanPropertiesLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=peak_OtherNonReportingSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_SHOPJVMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=peak_LabMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_SouthSanFranciscoJVsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_LifeScienceJVsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_NeedhamLandParcelJVMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=peak_LifeScienceJointVentureInSanFranciscoCaliforniaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=peak_LifeScienceJointVentureInSanFranciscoCaliforniaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=peak_OutpatientMedicalBuildingsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MinimumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_RangeAxis=srt_MaximumMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |